A recent RAND Corporation report found that prescription drug prices in the US are significantly higher than in other nations, averaging 256 percent of those seen in 32 other countries.
Notably, the...
Pfizer and BioNTech recently announced an advanced purchase agreement with COVAX for up to 40 million doses of its mRNA COVID-19 vaccine, BNT162b2.
The first doses of the vaccine are expected to be...
Novavax recently announced that its COVID-19 vaccine candidate, NVX-CoV2373, was 89.3 percent effective in the Phase 3 UK clinical trial.
The trial also found that the vaccine was 95.6 percent...
Recently, experts have considered delaying, skipping, or half-dosing Moderna and Pfizer-BioNTech’s COVID-19 vaccines to reach more people in need and create a more wide-spread...
Moderna recently announced that Swissmedic, the Swiss Agency for therapeutic products, has authorized its mRNA-based COVID-19 vaccine for use in Switzerland.
The Swiss authorization comes over a month...
Roche recently announced that HHS and the Department of Defense (DoD) will purchase additional doses of Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab.
Under the agreement,...
The National Institutes of Health (NIH) recently announced that a Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal COVID-19 antibody therapy.
The trial, ACTIV-2,...
Biogen recently announced that the first patient has been treated in the global clinical study of its rare disease drug, Spinraza (nusinersen), in infants who did not respond to its gene therapy,...
Moderna recently announced that the European Commission (EU) granted conditional marketing authorization (CMA) for its mRNA COVID-19 vaccine.
The authorization of COVID-19 Vaccine Moderna,...
Pfizer recently announced that the first participant has been dosed in the Phase 3 study to evaluate the safety of its investigational rare disease gene therapy candidate in boys with Duchenne muscular...
AstraZeneca recently announced that its COVID-19 vaccine has been granted emergency use authorization in India, Argentina, Dominican Republic, El Salvador, Mexico, and Morocco.
The authorization of...
Fujifilm Corporation will invest $40 million to establish a new processing facility to advance viral vector manufacturing and perform cutting-edge research in the field of advanced therapies in the...
FDA recently approved the first generic drug for the treatment of severe hypoglycemia, which may occur in patients with diabetes mellitus.
Amphastar Pharmaceutical’s generic of glucagon...
FDA is warning health officials to follow the authorized dosing schedules for COVID-19 vaccines as the first round of recipients become eligible to receive their second dose.
Despite discussions...
Moderna recently released a COVID-19 vaccine manufacturing update for its mRNA-based vaccine, mRNA-1273. The company announced that it is increasing its base-case global production estimate from 500 to...
AstraZeneca recently announced that its COVID-19 vaccine has been approved for emergency supply in the United Kingdom (UK).
This is the first emergency authorization for COVID-19 Vaccine...
Pfizer and BioNTech recently announced that an additional 100 million doses of their mRNA COVID-19 vaccine will go to 27 European Union (EU) member states this year.
The commitment comes just...
HHS recently announced three ways the federal government will continue to support COVID-19 testing efforts by states and authorities into 2021.
The initiative builds upon over $31 billion in...
GSK recently announced that FDA approved BENLYSTA (belimumab) as the first chronic disease treatment for adult patients with lupus nephritis (LN), who are receiving standard...
California Governor Gavin Newsom recently launched a campaign for safe, fair, and equitable distribution of a COVID-19 vaccine in all 58 counties of the state.
The “Vaccinate All 58”...
